Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness, safety and protection duration of COVID-19 inactivated vaccines
ChiCTR2100045353Phase 4Recruiting
- Sponsor
- Fujian Academy of Medical Sciences
- Start
- Apr 2021
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Fujian Academy of Medical Sciences. Primary endpoint: SARS-CoV-2 related antibodies. Started Apr 2021; status: recruiting.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2100045353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045353.